Detalhe da pesquisa
1.
Executive summary of the consensus document of the HIV quality of care indicators. GESIDA updated.
Enferm Infecc Microbiol Clin (Engl Ed)
; 40(1): 35-38, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991851
2.
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort.
Infect Dis Ther
; 11(3): 1177-1192, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35399147
3.
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.
PLoS One
; 16(4): e0249515, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33831047
4.
Monotherapy with darunavir/ritonavir is effective and safe in clinical practice.
J Int AIDS Soc
; 17(4 Suppl 3): 19813, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25397557